- $221.21m
- $154.31m
- $408.52m
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 78 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro
U.S. STOCKS ON THE MOVE-Super Micro Computer, WEX, MarketAxess
Nevro rises on deal from Globus Medical
U.S. STOCKS ON THE MOVE-Honeywell, Canadian National Railway, C.H. Robinson
Nevro surges after Q3 revenue beats estimates
U.S. RESEARCH ROUNDUP-Cable One, Neurogene, Topbuild
Nevro Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Nevro Q3 Revenue USD 96.91 Million Vs. IBES Estimate USD 93.1 Million
Nevro Corp expected to post a loss of 81 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
Medical device maker Nevro dips after lowering 2024 revenue forecast
Brief: Nevro Q2 Revenue USD 104.161 Million Vs. IBES Estimate USD 107.3 Million
Nevro Corp expected to post a loss of 68 cents a share - Earnings Preview
Nevro hits record low after Citi downgrades to 'sell'
Nevro Corp reports results for the quarter ended in March - Earnings Summary